Hi there and good morning...yes Gretchen I am back at least for awhile....I liked your response,except for the comment made regarding the information that copaxone reduces the progression of MS by only 40 percent. Its a bit beyond this. And ther are many other benefits of Copaxone other than slowing down progression.
I know that u are not a real fan of copaxone, but I for one am, so have to bring forward the positives....
If you are talking early treatment of MS before the actual dx of MS is made, then you are correct by saying that copaxone will reduced the risk of progression by 40 percent. There are some indications that this might for some reach 80 per cent.
But for people who have been dx with MS, and are on copaxone, the 15 year stats are a bit different. These stats are based on RRMS patients.
- 80 per cent of MS patients are still walking after the 15 years of being on copaxone,without any assistance and the same 80 per cent did not even in any way decline in disability...in fact 51 per cent of these people actually improved during the 15 year study.
- Copaxone reduced the number of lesions in patients by 63 percent, from the number that were detected during the initial dx.
- Copaxone repairs nerve damaged tissue
- Copaxone assists in the reduction of fatigue
- Copaxone has also been noted to assist the body in remylination and improvement in neuroprotectiveness
- Copaxone assists in the reduction of brain volume loss
- Copaxone reduces the number of relapses
There are lot of other stats that are available, but this gives a pretty good picture of what Copaxone can do for u...
Thanks and have a nice day